Emerging Technologies - Vivacta Ltd

www.vivacta.com

Vivacta Limited was founded in 2003 as Panopsys Ltd to exploit biological applications of a unique patented enabling technology to dramatically improve in vitro diagnostic (IVD) test performance at the point-of-care (PoC). In a groundbreaking development, Vivacta has recently shown proof-of-principle for the technology measuring a protein in a liquid sample by a simple homogeneous immunoassay without separation. The result is available in one minute from addition of the sample and sensitivity is below 1 attomole

Integrated Technologies Ltd is currently actively involved with the development of instrumentation for this technology.